RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Prenatal phthalate exposure and adverse birth outcomes in the USA
a prospective analysis of births and estimates of attributable burden and costs
Trasande, L., Nelson, M., Alshawabkeh, A., Barrett, E., Buckley, J., Dabelea, D., Dunlop, A., Herbstman, J., Meeker, J., Naidu, M., Newschaffer, C., Padula, A., Romano, M., Ruden, D., Sathyanarayana, S., Schantz, S., Starling, A., & Hamera, G. (2024). Prenatal phthalate exposure and adverse birth outcomes in the USA: a prospective analysis of births and estimates of attributable burden and costs. The Lancet Planetary Health, 8(2), e74-e85. https://doi.org/10.1016/S2542-5196(23)00270-X
Background Phthalates are synthetic chemicals widely used in consumer products and have been identified to contribute to preterm birth. Existing studies have methodological limitations and potential effects of di-2-ethylhexyl phthalate (DEHP) replacements are poorly characterised. Attributable fractions and costs have not been quantified, limiting the ability to weigh trade-offs involved in ongoing use. We aimed to leverage a large, diverse US cohort to study associations of phthalate metabolites with birthweight and gestational age, and estimate attributable adverse birth outcomes and associated costs. Methods In this prospective analysis we used extant data in the US National Institutes of Health Environmental influences on Child Health Outcomes (ECHO) Program from 1998 to 2022 to study associations of 20 phthalate metabolites with gestational age at birth, birthweight, birth length, and birthweight for gestational age z-scores. We also estimated attributable adverse birth outcomes and associated costs. Mother-child dyads were included in the study if there were one or more urinary phthalate measurements during the index pregnancy; data on child's gestational age and birthweight; and singleton delivery. Findings We identified 5006 mother-child dyads from 13 cohorts in the ECHO Program. Phthalic acid, diisodecyl phthalate (DiDP), di-n-octyl phthalate (DnOP), and diisononyl phthalate (DiNP) were most strongly associated with gestational age, birth length, and birthweight, especially compared with DEHP or other metabolite groupings. Although DEHP was associated with preterm birth (odds ratio 1 center dot 45 [95% CI 1 center dot 05-2 center dot 01]), the risks per log(10) increase were higher for phthalic acid (2 center dot 71 [1 center dot 91-3 center dot 83]), DiNP (2 center dot 25 [1 center dot 67-3 center dot 00]), DiDP (1 center dot 69 [1 center dot 25-2 center dot 28]), and DnOP (2 center dot 90 [1 center dot 96-4 center dot 23]). We estimated 56 595 (sensitivity analyses 24 003-120 116) phthalate-attributable preterm birth cases in 2018 with associated costs of US$3 center dot 84 billion (sensitivity analysis 1 center dot 63- 8 center dot 14 billion). Interpretation In a large, diverse sample of US births, exposure to DEHP, DiDP, DiNP, and DnOP were associated with decreased gestational age and increased risk of preterm birth, suggesting substantial opportunities for prevention. This finding suggests the adverse consequences of substitution of DEHP with chemically similar phthalates and need to regulate chemicals with similar properties as a class. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.